Actively Recruiting
Evaluating Tolerability of ePUHRT With Brachytherapy Boost
Led by Indiana University · Updated on 2025-09-26
31
Participants Needed
1
Research Sites
186 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the tolerability and toxicity of combining two radiation therapy methods for prostate cancer: Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT), which is an external beam radiotherapy with High Dose Rate Brachytherapy Boost (form of internal radiation where a cancer doctor implants a small plastic tube or balloon (catheter) in the tumor).
CONDITIONS
Official Title
Evaluating Tolerability of ePUHRT With Brachytherapy Boost
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years old or older at the time of informed consent
- Able to provide informed consent and HIPAA authorization
- Karnofsky performance score of 70 or higher
- Pathologically confirmed unfavorable intermediate, high, or very high-risk prostate cancer
- Candidate plans to undergo standard prostate high dose brachytherapy boost procedure
You will not qualify if you...
- Previous pelvic radiation treatment
- Prior rectal surgery preventing use of rectal ultrasound probe
- Evidence of nodal or distant disease on screening diagnostic tests
- Previous prostate surgery including prostatectomy, Holmium laser enucleation, or transurethral resection
- International Prostate Symptom Score (IPSS) greater than 16 despite medical therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, United States, 46202
Actively Recruiting
Research Team
O
Omar Ishaq, MD
CONTACT
K
Kathy Lauer, BA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here